Log In
BCIQ
Print this Print this
 

Hocena (Antroquinonol)

  Manage Alerts
Collapse Summary General Information
Company Golden Biotechnology Corp.
DescriptionCyclohexenone compound from extract of Antrodia camphorata
Molecular Target
Mechanism of ActionFarnesyl transferase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat non-small cell lung cancer (NSCLC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today